Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

OSANG LLC

Subsidiary ofOSANG LLCUEI: QL3TQ3Z96B74CAGE: 969A8

OSANG LLC is a federal contractor, registered under UEI QL3TQ3Z96B74 and CAGE code 969A8. It has been awarded $237,000,000 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

QL3TQ3Z96B74

CAGE Code

969A8

Entity Structure

Partnership or Limited Liability Partnership

Established

N/A

Business Classifications

For Profit OrganizationForeign Owned

NAICS Codes

325413In-Vitro Diagnostic Substance Manufacturing(Primary)
423450Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
541714Research and Development in Biotechnology (except Nanobiotechnology)
541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
621511Medical Laboratories

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

OSANG LLC specializes in the manufacturing of in-vitro diagnostic substances, with a focused capability in developing multi-antigen test platforms designed for rapid deployment during public health emergencies. Their technical expertise centers on the formulation, production, and quality assurance o...

OSANG LLC specializes in the manufacturing of in-vitro diagnostic substances, with a focused capability in developing multi-antigen test platforms designed for rapid deployment during public health emergencies. Their technical expertise centers on the formulation, production, and quality assurance of diagnostic reagents capable of simultaneously detecting multiple pathogens—specifically SARS-CoV-2 and Influenza A/B—enabling high-throughput surveillance and response capabilities. The company demonstrates proficiency in regulatory-compliant manufacturing processes aligned with clinical diagnostic standards, ensuring stability, specificity, and scalability of test kits under surge demand conditions. Their differentiation lies in agile, government-tailored production workflows that prioritize speed-to-market without compromising analytical accuracy or biosafety protocols. OSANG LLC has delivered diagnostic manufacturing solutions directly to the Department of Health and Human Services, supporting critical public health preparedness initiatives. The relationship reflects a targeted engagement in emergency response infrastructure, where the contractor serves as a specialized supplier of diagnostic reagents for federal biodefense and pandemic readiness programs. This singular but mission-critical partnership underscores their role in the federal biosurveillance ecosystem. The contractor’s primary industry focus is in NAICS 325413, which encompasses the production of diagnostic reagents and substances used in laboratory-based clinical testing. OSANG LLC operates within the niche of infectious disease diagnostics, positioning itself as a manufacturer of multiplex assay components rather than end-user devices. This vertical specialization aligns with federal priorities in pandemic preparedness and laboratory-based pathogen detection. OSANG LLC is a small business entity based in South Pasadena, California, with no publicly disclosed government certifications. Its geographic footprint is localized, but its market positioning is nationally relevant through direct support of federal health security objectives. The company’s operational model emphasizes precision manufacturing for high-stakes public health applications.

Key Performance Metrics

Awards Count

2

All time

Active

0

Currently performing

Completed

2

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with OSANG LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for OSANG LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in OSANG LLC's top NAICS codes and agencies

NAICS: 325412
New
DIBBS
Epinephrine Injector
Solicitation # SPE2D2-26-R-0009
Solicitation SPE2D2-26-R-0009 is a federal procurement issued by the Defense Logistics Agency Troop Support Medical Supply Chain for the acquisition of Epinephrine 0.3 MG/0.3 ML Injection Auto-Injectors in 2-count boxes. The government is seeking offers from manufacturers or distributors to ensure an uninterrupted supply, with a total contract duration not to exceed five years. The procurement is conducted as a lowest price technically acceptable acquisition, where awards are based on technical acceptability regarding requirements and past performance, followed by the lowest evaluated aggregate price. The estimated quantity for the base year and subsequent option years is 473,905 boxes per period. Offerors must submit their proposals electronically via DIBBS by November 16, 2026. Required documentation includes a signed SF 1449, a price proposal, and either a Letter of Certification for manufacturers or a Letter of Commitment from the manufacturer for dealers and suppliers. Strict quality and regulatory standards apply, including mandatory FDA clearance and compliance with current Good Manufacturing Practices. Packaging must feature child-proof closures, non-glass bottles with a minimum 100cc volume, and GS1-128 or HIBC compliant bar coding at the unit-of-use level encoding the National Drug Code. All contractors must also adhere to the Drug Supply Chain Security Act and various FAR and DFARS clauses regarding trade agreements and cybersecurity.
MEDICAL SUPPLY CHAIN FSGB

POSTED

about 8 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 325412
New
Federal
6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center
Solicitation # 36C24427Q0018
The Department of Veterans Affairs, Network Contracting Office 4, is soliciting quotations for an indefinite-quantity contract to provide essential radiopharmaceuticals and calibration sources for the Corporal Michael J. Crescenz VA Medical Center Nuclear Medicine Department. The contract covers a five-year period of performance from November 1, 2026, to October 31, 2031, consisting of a base year and four option years. The selected vendor must be licensed and accredited by the Nuclear Regulatory Commission and comply with all regulations from the DOT, NHPP, FDA, and OSHA. Deliveries are to be made to a secure location at the medical center, with routine orders due by 8:00 AM the following workday and same-day deliveries required within two hours of order placement during normal business hours. The scope of work includes the supply of various radiopharmaceutical kits and calibration sources, such as Co57 and Tc99m variants. Contractors must ensure all radioactive materials are clearly labeled with proper class and exposure levels, and unit doses must include preparation and expiration details. Additionally, the vendor must provide bar-labeled inserts compatible with the PineStar Nuclear Medicine Information Management System or provide a compatible system, including data migration and training, at no additional cost. Award will be based on a comparative evaluation of price and past performance, with a preference for HUBZone Small Business Concerns. Quotations must be submitted electronically to the Contracting Officer in two parts: a price quotation and past performance information from the last three years. Invoicing is to be handled monthly and submitted electronically via the Austin Payment Center.
244-NETWORK Contract Office 4 (36C244)

POSTED

about 8 hours ago

DEADLINE

in about 23 hours
View Details
NAICS: 325412
New
DIBBS
BENZOIN TINCTURE, COMPO
Solicitation # SPE2DP-26-T-5044
Solicitation SPE2DP-26-T-5044 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Benzoin Tincture, Compound, USP. The requirement consists of two line items totaling 14 units of 2 fl oz or 60 ml bottles, with 10 units for the first request and 4 units for the second. Delivery is required within 20 days after the order, with required delivery dates set for September 15 and 16, 2026. The items are to be delivered FOB Destination to locations in Richmond, Virginia, and Jersey City, New Jersey. The contract mandates strict adherence to medical quality and packaging standards. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers that comply with MIL-STD-2073-1E and DLA packaging requirements (RP001). The product must have a shelf life of 31 to 36 months, with no more than 21 months elapsed from the date of manufacture to the date of delivery. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and payment requests. The solicitation incorporates various FAR and DFARS clauses, including those regarding the Buy American and Balance of Payments Program, safeguarding covered defense information, and the prohibition of certain telecommunications equipment. Quotes must be submitted via the DLA Internet Bid Board System (DIBBS) by September 21, 2026. Inspection and acceptance will take place at the destination.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 2 days
View Details
NAICS: 325412
New
DIBBS
SKIN WASH, POISON IVY T
Solicitation # SPE2DP-27-T-0103
Solicitation SPE2DP-27-T-0103 is a federal procurement issued by the Defense Logistics Agency for the supply of one unit of skin wash for the treatment of poison ivy, oak, and sumac. The required item is a topical solution supplied in a one ounce tube, identified by NSN 6505016112071. This is a Type I (Code W) item with a non-extendable shelf life of 120 months, and it must have a minimum of 102 months of remaining shelf life upon receipt by the government. The delivery is set for FOB Destination to the West Virginia Army National Guard Medical Detachment in South Charleston, West Virginia, with a required delivery date of October 14, 2026, and a delivery window of 20 days after receipt of order. The contract mandates strict adherence to the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical marking, although MIL-STD-129 remains applicable for general packaging and labeling. Packaging must be commercial and sealed to prevent damage, following ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials. The procurement is regulated by the FDA, and the successful bidder must specify the source and part number. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and safeguarding of covered defense information.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details